Rate My Professor Adam Brentnall

Dr Adam Brentnall is Reader in Biostatistics at the Wolfson Institute of Population Health, Queen Mary University of London. He holds an MMath from the University of Sheffield, an MSc from the University of Southampton and a PhD from the University of Southampton. His research focuses on cancer prevention and early detection, with particular emphasis on risk stratification, and the design and analysis of epidemiological studies, clinical trials and laboratory studies. He also develops statistical methodology driven by these applications and collaborates across healthcare and biomedical science areas. Previously he worked on problems in operational research, including retail finance and aircraft scheduling. Dr Brentnall co-leads a research methods module for MSc programmes at Barts Cancer Institute and is a fellow of the Digital Environment Research Institute. He serves as a member of a NICE committee developing guidelines on identifying and managing familial and genetic risk of ovarian cancer, supports several clinical trial steering and data safety monitoring committees, and is a standing member of Cancer Research UK’s Expert Review Panel on Early Detection & Diagnosis Trials, Behavioural, Health Systems and Health Economics Research. Key publications include work on risk models for breast cancer and their validation (Statistical Science, 2020), standardized relative survival (Biometrics, 2017), long-term accuracy of breast cancer risk assessment (JAMA Oncology, 2018), and the concordance index for predictors of censored survival data (Statistical Methods in Medical Research, 2018).